MaaT Pharma SA MAAT.PA Stock
MaaT Pharma SA Price Chart
MaaT Pharma SA MAAT.PA Financial and Trading Overview
| MaaT Pharma SA stock price | 9.48 EUR |
| Previous Close | 7.5 EUR |
| Open | 7.5 EUR |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 7.5 - 7.6 EUR |
| 52 Week Range | 7.4 - 11.7 EUR |
| Volume | 23 EUR |
| Avg. Volume | 684 EUR |
| Market Cap | 91.05M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.8 EUR |
MAAT.PA Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 63.674713 |
| Price/Book (mrq) | 2.305126 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
MaaT Pharma SA Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -35.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.7 EUR |
| 52 Week Low | 7.4 EUR |
| 50-Day Moving Average | 8.78 EUR |
| 200-Day Moving Average | 8.98 EUR |
MAAT.PA Share Statistics
| Avg. Volume (3 month) | 684 EUR |
| Avg. Daily Volume (10-Days) | 572 EUR |
| Shares Outstanding | 11.52M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 32.04% |
| % Held by Institutions | 48.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -947.97% |
| Gross Margin | 76.29% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.43M EUR |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.09M EUR |
| EBITDA | -13375000 EUR |
| Net Income Avi to Common (ttm) | -13713000 EUR |
| Diluted EPS (ttm) | -1.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 3.297 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12605000 EUR |
| Levered Free Cash Flow (ttm) | N/A |
Profile of MaaT Pharma SA
| Country | France |
| State | N/A |
| City | Lyon |
| Address | 70 Avenue Tony Garnier |
| ZIP | 69007 |
| Phone | 33 4 28 29 14 00 |
| Website | https://www.maatpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 43 |
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
Q&A For MaaT Pharma SA Stock
What is a current MAAT.PA stock price?
MaaT Pharma SA MAAT.PA stock price today per share is 9.48 EUR.
How to purchase MaaT Pharma SA stock?
You can buy MAAT.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MaaT Pharma SA?
The stock symbol or ticker of MaaT Pharma SA is MAAT.PA.
Which industry does the MaaT Pharma SA company belong to?
The MaaT Pharma SA industry is Biotechnology.
How many shares does MaaT Pharma SA have in circulation?
The max supply of MaaT Pharma SA shares is 11.6M.
What is MaaT Pharma SA Price to Earnings Ratio (PE Ratio)?
MaaT Pharma SA PE Ratio is now.
What was MaaT Pharma SA earnings per share over the trailing 12 months (TTM)?
MaaT Pharma SA EPS is -1.7 EUR over the trailing 12 months.
Which sector does the MaaT Pharma SA company belong to?
The MaaT Pharma SA sector is Healthcare.